Fujian Cancer Hospital

This study tests a combination of two drugs, Sac-TMT and QL1706, in people whose cervical cancer has come back or spread. The goal is to see if the treatment can shrink tumors and help patients live longer. About 89 adults with certain types of cervical cancer will take part.

This study tests whether adding radiation therapy after surgery, along with immunotherapy, can help keep non-small cell lung cancer from returning in people whose cancer has spread to multiple lymph nodes. About 60 adults aged 18 to 75 will take part. The main goal is to see how …

This study tests whether adding a low-dose chemotherapy pill (capecitabine) to the standard two-drug combination of dalpiciclib and hormone therapy can help control advanced breast cancer that has spread to organs like the liver or lungs. About 258 women with HR+/HER2- breast can…

This study is testing whether adding the drug dalpiciclib to standard hormone therapy can help keep early-stage HR+/HER2- breast cancer from returning. About 2000 women with stage II or III breast cancer will receive either a lower dose for 3 years or a higher dose for 2 years. T…

This study tests a new approach for people with rectal cancer that has spread to the liver. It combines short-course radiation, chemotherapy (CAPOX), and an immunotherapy drug (QL1706) that targets two immune checkpoints. The goal is to improve how long the cancer stays under con…

This study tests whether giving a combination of two immunotherapy drugs (iparomlimab and tuvonralimab) along with chemotherapy before surgery can help people with locally advanced cervical cancer. The goal is to see if this approach can make the tumor disappear completely by the…